Optrex RE
Natural health product licensed in Canada
- Licence holder
- Reckitt Benckiser (Canada) Inc.
- NPN or DIN-HM
- 80058984
- Status
- Active licence
- Licence date
- 19 March 2015
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Ophthalmique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Hamamelis virginiana Source : Rameaux Extract : Matériel brut sec Extraction ratio : 1:2 Dry plant equivalent : 6.5 milligramme | 13 % (v/v) |
Non-medicinal ingredients
Glycérine, Borate de sodium, Acide borique, Eau, Chlorure de benzalkonium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 14 years | 2 Goutte(s) | minimum: 3 Tous les jours ; maximum: 6 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Herbal Medicine for the temporary relief of eye discomfort due to dryness of the eye or to exposure to wind or sun.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058984
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.